ARQT — ARCUTIS BIOTHERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  14 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ARCUTIS BIOTHERAPEUTICS INC (ARQT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.78% (2024 Q1)
Avg. % of fund
1.68%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 224,740 -187,153 -45.4% 1.12% $6.5M $29.04
2025 Q3 ADDED 411,893 +206,221 +100.3% 1.56% $7.8M $18.85
2025 Q2 ADDED 205,672 +105,672 +105.7% 0.93% $2.9M $14.02
2025 Q1 REDUCED 100,000 -340,073 -77.3% 0.01% $42K $15.64
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARQT price (monthly, adj. close)

Other funds also holding ARQT

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 15.34% Frazier Life Sciences Management, L.P. 3Y 7.7% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 7.12% Rubric Capital Management LP 3Y 7Y 2.87% MPM BioImpact LLC 3Y 1.77% Privium Fund Management B.V. 3Y 1.64% MYDA Advisors LLC 3Y 7Y 1.47% GILDER GAGNON HOWE & CO LLC 3Y 7Y 1.37% FISHMAN JAY A LTD/MI 3Y 7Y 1.35% Patient Square Capital LP 3Y 1.31%
← Back to STEMPOINT CAPITAL LP Holdings